Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease.
| Image |  |
|---|---|
| Description | scientific article published on 31 January 2018 |
| Author/s |
author: Thomas Ollila Peter J Quesenberry |
| Publication date | January 31, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |